These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25266533)

  • 1. Controlling strategy of dormant Mycobacterium tuberculosis.
    Gan Y; Guo S
    Chin Med J (Engl); 2014; 127(18):3316-21. PubMed ID: 25266533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dormant cells of Mycobacterium tuberculosis may be resuscitated by targeting-expression system of recombinant mycobacteriophage-Rpf: implication of shorter course of TB chemotherapy in the future.
    Gan Y; Yao Y; Guo S
    Med Hypotheses; 2015 May; 84(5):477-80. PubMed ID: 25691378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent and dormant tubercle bacilli and latent tuberculosis.
    Zhang Y
    Front Biosci; 2004 May; 9():1136-56. PubMed ID: 14977534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
    Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
    J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
    Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
    Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Liu R; Dang JN; Lee R; Lee JJ; Kesavamoorthy N; Ameri H; Rao N; Eoh H
    Microbiol Spectr; 2024 Aug; 12(8):e0078824. PubMed ID: 38916325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis: current state of knowledge: an epilogue.
    Leung CC; Lange C; Zhang Y
    Respirology; 2013 Oct; 18(7):1047-55. PubMed ID: 23837600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment.
    Kaur S; Angrish N; Gupta K; Tyagi AK; Khare G
    Infect Genet Evol; 2021 Jan; 87():104662. PubMed ID: 33278633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.
    Caño-Muñiz S; Anthony R; Niemann S; Alffenaar JC
    Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis: an overview.
    Cruz-Knight W; Blake-Gumbs L
    Prim Care; 2013 Sep; 40(3):743-56. PubMed ID: 23958367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting isocitrate lyase for the treatment of latent tuberculosis.
    Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
    Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost for tuberculosis care in developed countries: which data for an economic evaluation?
    Trieste L; Turchetti G
    J Rheumatol Suppl; 2014 May; 91():83-5. PubMed ID: 24789005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine strategies against latent tuberculosis infection.
    Andersen P
    Trends Microbiol; 2007 Jan; 15(1):7-13. PubMed ID: 17141504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.
    Ha SJ; Jeon BY; Kim SC; Kim DJ; Song MK; Sung YC; Cho SN
    Gene Ther; 2003 Sep; 10(18):1592-9. PubMed ID: 12907951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.